Jeffrey Rona

Chief Business and Financial Officer at Ovid Therapeutics

Speaker

Jeff Rona is currently the Chief Business and Financial Officer at Ovid. He leads Ovid’s corporate finance and business development strategy and the Company’s financial reporting and operations. Mr. Rona joined Ovid as consulting Chief Financial Officer in 2019 to assist the Company with strategic financing and business development. During his time with Ovid, he has completed numerous public financings, and business development transactions with Takeda, AstraZeneca, Graviton, Gensaic, Angelini Pharma, Healx and others. He has more than 25 years of experience as a former investment banker and a strategic financial executive with expertise in financial operations, investor relations and raising capital for public and private companies. Jeff has raised over $1 billion in more than 50 completed transactions. He previously held senior leadership positions for Danforth Advisors, GlobeImmune (NASDAQ: GMIB), AlgoRx Pharmaceuticals and Antigenics (NASDAQ: AGEN), and formed a successful life sciences financial advisory practice. Mr. Rona began his career at Coopers & Lybrand and UBS Investment Bank (NYSE: UBS). He holds a Bachelor of Science in Accounting from Case Western Reserve University.